| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Homology Medicines Inc (NASDAQ: FIXX)
FIXX Technical Analysis
5
| As on 9th Jun 2023 FIXX STOCK Price closed @ 1.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.44 & Strong Sell for SHORT-TERM with Stoploss of 3.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FIXXSTOCK Price
| Open | 1.09 | Change | Price | % |
| High | 1.14 | 1 Day | 0.02 | 1.82 |
| Low | 1.09 | 1 Week | 0.15 | 15.46 |
| Close | 1.12 | 1 Month | 0.16 | 16.67 |
| Volume | 104170 | 1 Year | -2.98 | -72.68 |
| 52 Week High 4.18 | 52 Week Low 0.91 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FIXX Daily Charts |
FIXX Intraday Charts |
Whats New @ Bazaartrend |
FIXX Free Analysis |
|
|
FIXX Important Levels Intraday
| RESISTANCE | 1.22 |
| RESISTANCE | 1.19 |
| RESISTANCE | 1.17 |
| RESISTANCE | 1.15 |
| SUPPORT | 1.09 |
| SUPPORT | 1.07 |
| SUPPORT | 1.05 |
| SUPPORT | 1.02 |
FIXX Forecast May 2024
| 4th UP Forecast | 3.99 |
| 3rd UP Forecast | 3.07 |
| 2nd UP Forecast | 2.5 |
| 1st UP Forecast | 1.93 |
| 1st DOWN Forecast | 0.31 |
| 2nd DOWN Forecast | -0.26 |
| 3rd DOWN Forecast | -0.83 |
| 4th DOWN Forecast | -1.75 |
FIXX Weekly Forecast
| 4th UP Forecast | 2.30 |
| 3rd UP Forecast | 1.92 |
| 2nd UP Forecast | 1.69 |
| 1st UP Forecast | 1.45 |
| 1st DOWN Forecast | 0.79 |
| 2nd DOWN Forecast | 0.55 |
| 3rd DOWN Forecast | 0.32 |
| 4th DOWN Forecast | -0.06 |
FIXX Forecast2024
| 4th UP Forecast | 7.67 |
| 3rd UP Forecast | 5.57 |
| 2nd UP Forecast | 4.27 |
| 1st UP Forecast | 2.97 |
| 1st DOWN Forecast | -0.73 |
| 2nd DOWN Forecast | -2.03 |
| 3rd DOWN Forecast | -3.33 |
| 4th DOWN Forecast | -5.43 |
Homology Medicines Inc ( NASDAQ USA Symbol : FIXX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FIXX Business Profile
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase I/II pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II. Homology Medicines, Inc. was incorporated in 2015 and is based in Bedford, Massachusetts. Address: One Patriots Park, Bedford, MA, United States, 01730
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service